Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. [electronic resource]
Producer: 20050801Description: 135-40 p. digitalISSN:- 0006-4971
- Acenocoumarol -- administration & dosage
- Administration, Oral
- Adolescent
- Adult
- Aged
- Anticoagulants -- administration & dosage
- Aryl Hydrocarbon Hydroxylases -- genetics
- Carcinoma, Hepatocellular
- Cell Line, Tumor
- Cytochrome P-450 CYP2C9
- Drug Resistance -- genetics
- Female
- Gene Frequency
- Genes, Reporter
- Haplotypes
- Humans
- Linear Models
- Liver Neoplasms
- Luciferases -- genetics
- Male
- Middle Aged
- Mixed Function Oxygenases -- genetics
- Predictive Value of Tests
- Vitamin K Epoxide Reductases
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.